Issie Kirby
Stock Analyst at Redburn Atlantic
(0.28)
# 4,019
Out of 4,814 analysts
7
Total ratings
25%
Success rate
-16.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Issie Kirby
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DXCM DexCom | Upgrades: Buy | $85 → $115 | $66.11 | +73.95% | 2 | Feb 3, 2025 | |
| ALC Alcon | Upgrades: Neutral | n/a | $91.38 | - | 1 | Oct 10, 2024 | |
| TNDM Tandem Diabetes Care | Initiates: Buy | $60 | $16.39 | +266.08% | 1 | May 30, 2024 | |
| PODD Insulet | Initiates: Buy | $235 | $238.39 | -1.42% | 1 | May 30, 2024 | |
| COO The Cooper Companies | Upgrades: Buy | $125 | $78.74 | +58.76% | 2 | Mar 19, 2024 |
DexCom
Feb 3, 2025
Upgrades: Buy
Price Target: $85 → $115
Current: $66.11
Upside: +73.95%
Alcon
Oct 10, 2024
Upgrades: Neutral
Price Target: n/a
Current: $91.38
Upside: -
Tandem Diabetes Care
May 30, 2024
Initiates: Buy
Price Target: $60
Current: $16.39
Upside: +266.08%
Insulet
May 30, 2024
Initiates: Buy
Price Target: $235
Current: $238.39
Upside: -1.42%
The Cooper Companies
Mar 19, 2024
Upgrades: Buy
Price Target: $125
Current: $78.74
Upside: +58.76%